Literature DB >> 10954530

Response of foot-and-mouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity.

S Sierra1, M Dávila, P R Lowenstein, E Domingo.   

Abstract

Passage of foot-and-mouth disease virus (FMDV) in cell culture in the presence of the mutagenic base analog 5-fluorouracil or 5-azacytidine resulted in decreases of infectivity and occasional extinction of the virus. Low viral loads and low viral fitness enhanced the frequency of extinction events; this finding was shown with a number of closely related FMDV clones and populations differing by up to 10(6)-fold in relative fitness in infections involving either single or multiple passages in the absence or presence of the chemical mutagens. The mutagenic treatments resulted in increases of 2- to 6.4-fold in mutation frequency and up to 3-fold in mutant spectrum complexity. The largest increase observed corresponded to the 3D (polymerase)-coding region, which is highly conserved in nonmutagenized FMDV populations. As a result, nucleotide sequence heterogeneity for the 3D-coding region became very similar to that for the variable VP1-coding region in FMDVs multiply passaged in the presence of chemical mutagens. The results suggest that strategies to combine reductions of viral load and viral fitness could be effectively associated with extinction mutagenesis as a potential new antiviral strategy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10954530      PMCID: PMC116341          DOI: 10.1128/jvi.74.18.8316-8323.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases.

Authors:  J Cline; J C Braman; H H Hogrefe
Journal:  Nucleic Acids Res       Date:  1996-09-15       Impact factor: 16.971

2.  Virologic and immunologic benefits of initial combination therapy with zidovudine and zalcitabine or didanosine compared with zidovudine monotherapy. Wellcome Resistance Study Collaborative Group.

Authors:  R T Schooley; C Ramirez-Ronda; J M Lange; D A Cooper; J Lavelle; L Lefkowitz; M Moore; B A Larder; M St Clair; J W Mulder; R McKinnis; K N Pennington; P R Harrigan; I Kinghorn; H Steel; J F Rooney
Journal:  J Infect Dis       Date:  1996-06       Impact factor: 5.226

Review 3.  Mechanisms of retroviral mutation.

Authors:  B D Preston; J P Dougherty
Journal:  Trends Microbiol       Date:  1996-01       Impact factor: 17.079

4.  Differential restrictions on antigenic variation among antigenic sites of foot-and-mouth disease virus in the absence of antibody selection.

Authors:  A Holguín; J Hernández; M A Martínez; M G Mateu; E Domingo
Journal:  J Gen Virol       Date:  1997-03       Impact factor: 3.891

5.  Human immunodeficiency virus type 1 reverse transcriptase: role of Tyr115 in deoxynucleotide binding and misinsertion fidelity of DNA synthesis.

Authors:  A M Martín-Hernández; E Domingo; L Menéndez-Arias
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

6.  A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Authors:  S M Hammer; K E Squires; M D Hughes; J M Grimes; L M Demeter; J S Currier; J J Eron; J E Feinberg; H H Balfour; L R Deyton; J A Chodakewitz; M A Fischl
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

7.  Long-term, large-population passage of aphthovirus can generate and amplify defective noninterfering particles deleted in the leader protease gene.

Authors:  N Charpentier; M Dávila; E Domingo; C Escarmís
Journal:  Virology       Date:  1996-09-01       Impact factor: 3.616

8.  Genetic lesions associated with Muller's ratchet in an RNA virus.

Authors:  C Escarmís; M Dávila; N Charpentier; A Bracho; A Moya; E Domingo
Journal:  J Mol Biol       Date:  1996-11-29       Impact factor: 5.469

9.  Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party.

Authors:  J J Eron; S L Benoit; J Jemsek; R D MacArthur; J Santana; J B Quinn; D R Kuritzkes; M A Fallon; M Rubin
Journal:  N Engl J Med       Date:  1995-12-21       Impact factor: 91.245

10.  Negative effects of chemical mutagenesis on the adaptive behavior of vesicular stomatitis virus.

Authors:  C H Lee; D L Gilbertson; I S Novella; R Huerta; E Domingo; J J Holland
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

View more
  91 in total

1.  Distribution of spontaneous mutants and inferences about the replication mode of the RNA bacteriophage phi6.

Authors:  Lin Chao; Camilla U Rang; Linda E Wong
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity.

Authors:  A Grande-Pérez; S Sierra; M G Castro; E Domingo; P R Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-05       Impact factor: 11.205

3.  Biased hypermutagenesis associated with mutations in an untranslated hairpin of an RNA virus.

Authors:  John C McCormack; Anne E Simon
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 4.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

Review 5.  Viral mutation rates.

Authors:  Rafael Sanjuán; Miguel R Nebot; Nicola Chirico; Louis M Mansky; Robert Belshaw
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

6.  Exploiting drug repositioning for discovery of a novel HIV combination therapy.

Authors:  Christine L Clouser; Steven E Patterson; Louis M Mansky
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

7.  Mutagenesis-induced, large fitness variations with an invariant arenavirus consensus genomic nucleotide sequence.

Authors:  Ana Grande-Pérez; Gema Gómez-Mariano; Pedro R Lowenstein; Esteban Domingo
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

8.  Theory of lethal mutagenesis for viruses.

Authors:  J J Bull; R Sanjuán; C O Wilke
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

9.  Hidden virulence determinants in a viral quasispecies in vivo.

Authors:  Marta Sanz-Ramos; Fayna Díaz-San Segundo; Cristina Escarmís; Esteban Domingo; Noemí Sevilla
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

10.  T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro.

Authors:  Tatiana Baranovich; Sook-San Wong; Jianling Armstrong; Henju Marjuki; Richard J Webby; Robert G Webster; Elena A Govorkova
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.